All In Biotech

Free tool

FAERS Monitor: Ajovy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761089 or its brand name (Ajovy, Fremanezumab-Vfrm). Reports on generic versions are filed under their own applications.

Reports

11,839

Serious

3,963

33% of reports

Hospitalization

869

Death reported

117

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • accidental exposure to product1,501
  • injection site pain1,358
  • migraine1,114
  • drug ineffective951
  • headache778
  • injection site erythema685
  • device leakage576
  • device malfunction521
  • fatigue518
  • nausea518
  • injection site pruritus511
  • injection site swelling462
  • drug dose omission by device455
  • dizziness414
  • incorrect dose administered by device402

Reports by year received

View as table
YearReports
20151
20163
20173
2018177
20191,390
20201,047
20211,421
20221,590
20231,420
20242,163
20251,484
20261,140

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,320 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
incorrect dose administered by deviceSignal40227.725.110,157
accidental exposure to productSignal1,50126.225.036,068
device leakageSignal57623.922.112,477
migraineSignal1,11421.019.821,009
injection site pruritusSignal51113.612.55,951
device malfunctionSignal52113.312.25,871
injection site swellingSignal46210.89.84,076
drug dose omission by deviceSignal45510.49.53,838
injection site erythemaSignal6859.99.25,446
injection site painSignal1,3587.97.58,256
headacheSignal7782.22.1527
dizziness4141.51.364
drug ineffective9511.31.263
fatigue5181.21.115
nausea5181.21.112

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.